Cleared Traditional

K810214 - DAC-CEL DIAGNATAL

K810214 is the FDA 510(k) clearance for DAC-CEL DIAGNATAL by Burroughs Wellcome Co.. It is a Class 2 Chemistry device (product code JHI) cleared through the Traditional 510(k) pathway after a 38-day FDA review.

K810214 · Burroughs Wellcome Co. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1981
Decision
38d
Days
Class 2
Risk

K810214 is an FDA 510(k) clearance for the DAC-CEL DIAGNATAL. Classified as Visual, Pregnancy Hcg, Prescription Use (product code JHI), Class II - Special Controls.

Submitted by Burroughs Wellcome Co. (Mchenry, US). The FDA issued a Cleared decision on March 6, 1981 after a review of 38 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Burroughs Wellcome Co. devices

Submission Details

510(k) Number K810214 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 27, 1981
Decision Date March 06, 1981
Days to Decision 38 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 88d · This submission: 38d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JHI Visual, Pregnancy Hcg, Prescription Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHI Visual, Pregnancy Hcg, Prescription Use

All 206
Devices cleared under the same product code (JHI) and FDA review panel - the closest regulatory comparables to K810214.
CONCEP-7-BHCG
K812156 · Leeco Diagnostics, Inc. · Aug 1981
HCG RADIOIMMUNOASSAY KIT (125I)
K811421 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jul 1981
HCG RADIOIMMUNOASSAY
K811116 · Hoffmann-La Roche, Inc. · May 1981
BETA-TEC QUALITATIVE
K802999 · Armkel, LLC · Dec 1980
GAMMADAB B-HCG RADIOIMMUNOASSAY KIT
K801409 · Travenol Laboratories, S.A. · Jul 1980
ROCHE HCG STANDARDS
K801244 · Hoffmann-La Roche, Inc. · Jun 1980